Cytokines associated with prolonged Cytopenia after axicabtagene ciloleucel in patients with refractory large B-cell lymphoma

被引：1
|
作者：
Strati, Paolo [1 ]
Puebla-Osorio, Nahum [1 ]
Han, Guangchun [1 ]
Westin, Jason [1 ]
Nastoupil, Loretta [1 ]
Samaniego, Felipe [1 ]
Fowler, Nathan [1 ]
Fayad, Luis [1 ]
Lee, Hun Ju [1 ]
Flowers, Christopher [1 ]
Srour, Samer [1 ]
Watson, Grace [1 ]
Wang, Linghua [1 ]
Green, Michael [1 ]
Neelapu, Sattva [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-2049
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2049
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Cost-effectiveness of axicabtagene ciloleucel for adult patients with relapsed or refractory large B-cell lymphoma in the United States
    Roth, Joshua A.
    Sulliyan, Sean D.
    Lin, Vincent W.
    Bansal, Aasthaa
    Purdum, Anna G.
    Nayale, Lynn
    Cheng, Paul
    Ramsey, Scott D.
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (12) : 1238 - 1245
  • [42] No Impact of Prophylactic Corticosteroid Use in Patients Receiving Axicabtagene Ciloleucel for Large B-Cell Lymphoma
    Melody, Megan
    Franco, Stephanie
    Odetola, Oluwatobi
    Lin, Adam
    Moreira, Jonathan
    Carson, Kenneth
    Ma, Shuo
    Winter, Jane N.
    Gordon, Leo
    Karmali, Reem
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S611 - S612
  • [43] Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
    Locke, F. L.
    Miklos, D. B.
    Jacobson, C. A.
    Perales, M-A
    Kersten, M-J
    Oluwole, O. O.
    Ghobadi, A.
    Rapoport, A. P.
    McGuirk, J.
    Pagel, J. M.
    Munoz, J.
    Farooq, U.
    van Meerten, T.
    Reagan, P. M.
    Sureda, A.
    Flinn, I. W.
    Vandenberghe, P.
    Song, K. W.
    Dickinson, M.
    Minnema, M. C.
    Riedell, P. A.
    Leslie, L. A.
    Chaganti, S.
    Yang, Y.
    Filosto, S.
    Shah, J.
    Schupp, M.
    To, C.
    Cheng, P.
    Gordon, L., I
    Westin, J. R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (07): : 640 - 654
  • [44] Impact of hypoalbuminemia on the prognosis of relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel
    Melody, Megan
    Gandhi, Sangeetha
    Rahman, Zaid Abdel
    Lengerke-Diaz, Paula
    Gannon, Nicole
    Rosenthal, Allison
    Truong, Tuan
    Novo, Mattia
    Brandes, Eva
    Lange, Gina
    Estby, Breana
    Johnston, Patrick
    Ansell, Steve
    Bennani, N. Nora
    Paludo, Jonas
    Bisneto, Jose Villasboas
    Ayala, Ernesto
    Tun, Han W.
    Murthy, Hemant S.
    Roy, Vivek
    Foran, James
    Castro, Januario
    Lin, Yi
    Kharfan-Dabaja, Mohamed A.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (01) : 48 - 53
  • [45] Long-Term Survival and Gradual Recovery of B Cells in Patients With Refractory Large B-Cell Lymphoma Treated With Axicabtagene Ciloleucel
    Jacobson, Caron
    Locke, Frederick L.
    Ghobadi, Armin
    Miklos, David B.
    Lekakis, Lazaros J.
    Oluwole, Olalekan O.
    Lin, Yi
    Braunschweig, Ira
    Hill, Brian T.
    Timmerman, John M.
    Deol, Abhinav
    Reagan, Patrick M.
    Stiff, Patrick J.
    Flinn, Ian W.
    Farooq, Umar
    Goy, Andre H.
    McSweeney, Peter A.
    Munoz, Javier
    Siddiqi, Tanya
    Rossi, John M.
    Bot, Adrian
    Zheng, Lianqing
    Vezan, Remus
    Bashir, Zahid
    Kim, Jenny J.
    Chu, Rong
    Neelapu, Sattva S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (03) : 4 - 5
  • [46] Second-Line Axicabtagene Ciloleucel Improves OS in Early Relapsed or Refractory Large B-Cell Lymphoma
    O'Brien, Susan
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (07) : 360 - 361
  • [47] Long-term survival and gradual recovery of B cells in patients with refractory large B-cell lymphoma treated with axicabtagene ciloleucel
    Jacobson, Caron A.
    Locke, Fredrick L.
    Ghobadi, Armin
    Miklos, David B.
    Lekakis, Lazaros J.
    Oluwole, Olalekan O.
    Lin, Yi
    Braunschweig, Ira
    Hill, Brian T.
    Timmerman, John M.
    Deol, Abhinav
    Reagan, Patrick M.
    Stiff, Patrick
    Flinn, Ian W.
    Farooq, Umar
    Goy, Andre H.
    McSweeney, Peter A.
    Munoz, Javier
    Siddiqi, Tanya
    Rossi, John M.
    Bot, Adrian A.
    Zheng, Lianqing
    Vezan, Remus
    Bashir, Zahid
    Kim, Jenny J.
    Chu, Rong
    Neelapu, Sattva S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 143 - 145
  • [48] High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma
    Dean, Erin A.
    Mhaskar, Rahul S.
    Lu, Hong
    Mousa, Mina S.
    Krivenko, Gabriel S.
    Lazaryan, Aleksandr
    Bachmeier, Christina A.
    Chavez, Julio C.
    Nishihori, Taiga
    Davila, Marco L.
    Khimani, Farhad
    Liu, Hien D.
    Pinilla-Ibarz, Javier
    Shah, Bijal D.
    Jain, Michael D.
    Balagurunathan, Yoganand
    Locke, Frederick L.
    BLOOD ADVANCES, 2020, 4 (14) : 3268 - 3276
  • [49] Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphoma
    Dean, Erin A.
    Kimmel, Gregory J.
    Frank, Matthew J.
    Bukhari, Ali
    Hossain, Nasheed M.
    Jain, Michael D.
    Dahiya, Saurabh
    Miklos, David B.
    Altrock, Philipp M.
    Locke, Frederick L.
    BLOOD ADVANCES, 2023, 7 (16) : 4608 - 4618
  • [50] EMA Review of Axicabtagene Ciloleucel (Yescarta) for the Treatment of Diffuse Large B-Cell Lymphoma
    Papadouli, Irene
    Mueller-Berghaus, Jan
    Beuneu, Claire
    Ali, Sahra
    Hofner, Benjamin
    Petavy, Frank
    Tzogani, Kyriaki
    Miermont, Anne
    Norga, Koenraad
    Kholmanskikh, Olga
    Leest, Tim
    Schuessler-Lenz, Martina
    Salmonson, Tomas
    Gisselbrecht, Christian
    Garcia, Jordi Llinares
    Pignatti, Francesco
    ONCOLOGIST, 2020, 25 (10): : 894 - 902
12345